The Efficacy & Safety of the Postoperative Adjuvant Treatment in Patients

See also
Status	Clinical Trial	Phase
Completed	`NCT02865889` - Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications	N/A
Completed	`NCT00377520` - A Trial for Patients With Advanced/Recurrent Endometrial Cancer	Phase 2
Recruiting	`NCT05007106` - MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)	Phase 2
Recruiting	`NCT05001282` - A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)	Phase 1/Phase 2
Active, not recruiting	`NCT05682950` - Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer	Phase 2
Not yet recruiting	`NCT05974995` - Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer	N/A
Recruiting	`NCT03291275` - Survival Outcomes of Uterine Malignancies in Chinese Population	N/A
Recruiting	`NCT03291106` - Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer
Completed	`NCT00341458` - Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics
Terminated	`NCT05067972` - A Study of PF-07260437 in Advanced or Metastatic Solid Tumors	Phase 1
Recruiting	`NCT05795244` - Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC)	Phase 2
Recruiting	`NCT05770102` - DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition	Phase 2/Phase 3
Active, not recruiting	`NCT04865289` - Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study	Phase 3
Completed	`NCT03270995` - Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study	N/A
Terminated	`NCT01969396` - Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology	N/A
Completed	`NCT01460979` - Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma	Phase 2
Active, not recruiting	`NCT05869123` - Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer	Phase 1/Phase 2
Terminated	`NCT02900248` - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Active, not recruiting	`NCT05588076` - Endometrial Lesions Predictions
Active, not recruiting	`NCT03935282` - Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors	N/A

NCT number	NCT01820858
Study type	Interventional
Source	Huazhong University of Science and Technology
Contact
Status	Active, not recruiting
Phase	Phase 3
Start date	November 2012
Completion date	December 2026

The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma — EC-01

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms